In 2020 digital health has become more important than ever. In response to this, on April 20th, G4A launched its 2020 Partnership Programme, offering entrepreneurs and companies alike the chance to collaborate and partner with Bayer, and create innovative integrated healthcare solutions.
This year, the G4A Partnership Programme is looking for companies in the areas of: Cardiometabolic and Renal Diseases, Oncology, Women’s Health, and Pharmacovigilance. Applicants can choose between two tracks to partner with Bayer: the ‘Growth Track’, which is designed for early stage companies (Seed-Series A) or the ‘Advance Track’, which is for mature companies with a product or solution already in the market with traction.
Successful applicants, or ‘partners’ as they will end up being, will benefit from Bayer’s global presence, business acumen and mentorship to take their healthcare business to the next level. You’ll also have the opportunity to participate in meetup events, meet strategic partners, and form partnerships with fellow healthtech experts that will be mutually beneficial. Plus, you automatically join the G4A Alumni network of hundreds of like-minded people, who continue to change the experience of health.
Since launching in 2013, G4A has worked with numerous startups to help develop and deliver meaningful, technological innovations, and results. To date, through the Bayer G4A Partnerships Programme, they have supported over 150 digital health companies resulting in more than 30 direct collaborations operating in more than 13 countries, developing and promoting collaborative health care technology projects around the world.
Applications are now open till June 30th, 11:59 CET! For more information and to apply, visit their website.